Meridian Bioscience Inc
NASDAQ:VIVO
Operating Income
Forecast
Operating Income Estimate
Meridian Bioscience Inc
For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's operating income is 5%. The projected CAGR for the next 1 year is -38%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is VIVO's stock price target?
Not Available
VIVO doesn't have any price targets made by Wall Street professionals.
What is Meridian Bioscience Inc's Revenue forecast?
Projected CAGR
-12%
For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's revenue is 7%. The projected CAGR for the next 1 year is -12%.
What is Meridian Bioscience Inc's Operating Income forecast?
Projected CAGR
-38%
For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's operating income is 5%. The projected CAGR for the next 1 year is -38%.
What is Meridian Bioscience Inc's Net Income forecast?
Projected CAGR
-13%
For the last 8 years the compound annual growth rate for Meridian Bioscience Inc's net income is 3%. The projected CAGR for the next 1 year is -13%.